Use of WeChat-based patient-doctor interaction improves patient experience of Helicobacter pylori treatment: a randomized controlled trial - Takeaways - MDSpire

Use of WeChat-based patient-doctor interaction improves patient experience of Helicobacter pylori treatment: a randomized controlled trial

  • By

  • Boshen Lin

  • Wenlin Zhang

  • Jinghui Zhang

  • Minjuan Lin

  • Jing Liu

  • Zhongxue Han

  • Yuming Ding

  • Qingzhou Kong

  • Miao Duan

  • Yueyue Li

  • Xiuli Zuo

  • Yanqing Li

  • May 29, 2026

  • 0 min

Share

  • 1

    The study evaluated a WeChat-based patient-doctor interaction system to improve patient experience during H. pylori treatment.

  • 2

    Patients in the WPDI group reported higher satisfaction rates (90.3%) compared to the control group (74.9%) during H. pylori therapy.

  • 3

    Eradication rates for H. pylori were similar between the WPDI group and control group, indicating no significant improvement in treatment outcomes.

  • 4

    The WPDI group experienced lower levels of worry and perturbation during treatment compared to the control group.

  • 5

    The study highlights the importance of effective communication in enhancing patient experience during complex treatment regimens.

Original Source(s)

Use of WeChat-based patient-doctor interaction improves patient experience of Helicobacter pylori treatment: a randomized controlled trial

  • by Boshen Lin, Wenlin Zhang, Jinghui Zhang, Minjuan Lin, Jing Liu, Zhongxue Han, Yuming Ding, Qingzhou Kong, Miao Duan, Yueyue Li, Xiuli Zuo, Yanqing Li

  • May 29, 2026

Related Content

The innovation trap: How pharma weaponizes a word to extend monopolies

Predictors of cough resolution following endoscopic minimally invasive treatment in patients with GERD and chronic cough: a retrospective study

FOXA2 in cancer: from fundamental biology to clinical translation